The Diagnosis Value of Serum Marker in Stroke Associated With Nonvalvular Atrial Fibrillation. (CE)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02181374
Recruitment Status : Unknown
Verified December 2015 by Xijing Hospital. Recruitment status was: Recruiting
First Posted : July 3, 2014
Last Update Posted : January 1, 2016
First Affiliated Hospital Xi'an Jiaotong University
The purpose of this study is to evaluate the diagnostic value of serum NT - proBNP in stroke associated with nonvalvular atrial fibrilltion.
Condition or disease
All included in the cases in 7 days of blood samples, the detection of serum NT - proBNP.Through the single factor analysis to determine the serum NT - proBNP central source sex stroke prediction values.
The diagnostic value of serum NT - proBNP in stroke associated with nonvalvular atrial fibrilltion [ Time Frame: 34 months ]
All included in the cases in 7 days of blood samples , the detection of serum NT - proBNP.Through the single factor analysis to determine the prediction values of serum NT - proBNP in stroke associated with nonvalvular atrial fibrilltion.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
18 Years to 85 Years (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
18 ≤ Age ≤ 85; meet the clinical diagnostic criteria for acute ischemic stroke; onset within 24 hours at the same time more than one hour; it was diagnosed with experiential doctor.
18 ≤ Age ≤ 85;
Meet the clinical diagnostic criteria for acute ischemic stroke;
onset within 7 days;
Severe systemic disease (chronic inflammation, infection, blood system diseases, cancer, kidney failure, liver failure,heart failure);
Nearly a month history of myocardial infarction;
Serious neurological disease that the diagnosis is unclear;